InvestorsHub Logo

joboggi

10/25/14 5:58 AM

#109585 RE: Solantey #109582

There is a really big hole in that article, it is the absence of MANF.

Now, that does not mean that MANF will be denied orphan status, it just means that JN did not think that AMBS warranted inclusion in his article on orphan status, and he is one of the biggest AMBS backers.

Now, biotechs are BEST when anticipating news, and so while the orphan status indication is not going to come tomorrow, an anticipation by the market that it will come is great for those who want to be in the stock.

Regardless of the presence of that graph showing increased chances for eventual approval, I have more reservations that MANF will ever get to the clinic.

Some will say that means I am against MANF. That is not true, you never know until you test, and they will be testing MANF. Right now, that is where the value lies.